Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance

Adaptive Biotechnologies CorpTrade
YieldMax TSLA Option Income Strategy ETFTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while YieldMax TSLA Option Income Strategy ETF trades at $21.88. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, YieldMax TSLA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.

ADPTTSLY
Market Cap
$4.04B
Sector
HealthIncome / Options Overlay
52-Week High
$25.45$48.25
52-Week Low
$12.30$20.49
Enterprise Value
$4.10B

Returns comparison

Trailing returns across standard periods

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About YieldMax TSLA Option Income Strategy ETF

TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.

Read more on TSLY